Search

everythinglearnresearchcommunity

for

Search:↓

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

The pseudo 'fringe sign' can also appear in frontal fibrosing alopecia, not just in traction alopecia, showing that this condition may be more common than thought.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

Agarose/fucoidan hydrogels may help treat diabetes by supporting pancreatic cell growth.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Overexpressing follistatin in mice delays wound healing and reduces scar size.

MAGP-1 decreases with age, leading to weaker, sagging skin.

Increasing the levels of a protein called FGF9 can promote hair growth, but humans may not respond the same way due to a lack of certain cells.

Sunscreen use is linked to frontal fibrosing alopecia, especially in males.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

Fibroblast Growth Factors (FGFs) are important for tissue repair and regeneration, influencing cell behavior and other factors involved in healing, and are crucial in processes like wound healing, bone repair, and hair growth.

Researchers identified a new variant of the FGF5 gene in sheep that affects hair length.

Combining nanofat with FUE improves scar appearance and function better than FUE alone.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Contact allergies might contribute to frontal fibrosing alopecia.

FUE is a less invasive hair restoration method that avoids visible scars and reduces recovery time.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

FP-1 is a key protein in rat hair growth, active only during the growth phase.

Fetuin A may increase collagen production and promote scarring.

Certain genetic factors may contribute to frontal fibrosing alopecia in Brazil.

The woman's skin and hair symptoms were confirmed as frontal fibrosing alopecia, and while facial papules are common in such cases, there's no effective local treatment, but systemic treatments can help.

Ficus religiosa and Morus alba extracts improved hair growth and follicle regeneration in mice.

Fibromodulin treatment helps reduce scarring and improves wound healing by making it more like fetal healing.

Lower PPARγ levels and specific gene variations are linked to more severe Frontal Fibrosing Alopecia.

5-α-reductase inhibitors, intralesional steroids, and hydroxychloroquine are the most effective treatments for frontal fibrosing alopecia.

FGF-9 speeds up the early development of certain organs, showing potential for organ regeneration.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.